Trial Profile
Phase III Clinical Study to Evaluate Efficacy and Safety of CDB-2914 Compared with Leuprorelin Acetate in Patients with Uterine Myoma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Ulipristal (Primary) ; Leuprorelin
- Indications Uterine leiomyoma
- Focus Therapeutic Use
- Sponsors ASKA Pharmaceutical
- 11 Mar 2021 Status changed from active, no longer recruiting to completed, as per results published in the Fertility and Sterility
- 11 Mar 2021 Primary endpoint has been met. (Percentage of amenorrheic patients), as per results published in the Fertility and Sterility
- 11 Mar 2021 Results published in the Fertility and Sterility